Atlas Trials

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898

Clinical trial NCT03140072 · TERMINATED

Trial details

NCT number
NCT03140072
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Asthma
Start date
2017-05-10
Primary completion
2017-08-23
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.